Pharmaceutical giant AstraZeneca entered into a new global development and commercialisation agreement with Ionis Pharmaceuticals for eplontersen, a drug to treat transthyretin amyloidosis, a systemic,...
GlaxoSmithKline and Vir Biotechnology said preclinical data showed their monoclonal antibody retained efficacy against omicron, the heavily muted variant of Covid-19.
Concrete levelling technology group Somero Enterprises upgraded its annual earnings, revenue and cash guidance amid continued strong trading in North America.
Specialist lender Paragon Banking booked an 81% jump in full-year profit, as lending and deposit volumes rose, margins expanded and credit quality improved.